Stay updated on SB2 vs Remicade in RA Clinical Trial.
Sign up to get notified when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.

Latest updates to the SB2 vs Remicade in RA Clinical Trial. page
- CheckyesterdayChange DetectedThe funding-status warning at the top of the page has been removed, removing a non-essential alert. The core trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoChange DetectedThe MedlinePlus related topics section now includes Rheumatoid Arthritis and MedlinePlus Genetics. This is a minor update that does not change trial information or required user actions.SummaryDifference0.2%

- Check15 days agoChange DetectedThe new screenshot reflects mostly visual/layout tweaks and does not modify essential study details such as eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check29 days agoChange DetectedAdded a MedlinePlus Genetics topic on Rheumatoid arthritis to the page.SummaryDifference0.3%

- Check44 days agoChange Detected- Added a government-operating-status notice and links, indicating updated operating information and that the NIH Clinical Center is open. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check51 days agoChange DetectedUpdates include a new version tag (v3.1.0) and removal of the Rheumatoid arthritis topic under MedlinePlus Genetics, replacing the older revision tag (v3.0.2) with the new version.SummaryDifference0.4%

Stay in the know with updates to SB2 vs Remicade in RA Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.